Exosomal circRNA protects against myocardial injury—new insights into RNA-based cardioprotection.
doi.org/10.15212/CVI...
#circRNA #Exosomes #MyocardialInjury #Cardioprotection

Selective ROCK2 inhibition reduces microvascular obstruction but does not reduce myocardial infarction after ischaemia and reperfusion Myocardial ischaemia/reperfusion (I/R) injury causes infarction, microvascular obstruction (MVO), and haemorrhage. MVO, often driven by vasospasm, lac…

Stuck between a ROCK2 and a hard place?
New research just out shows selective ROCK2 inhibition reduces microvascular obstruction after myocardial I/R but doesn’t limit infarct size. Highlights distinct roles for ROCK isoforms in #cardioprotection. 🫀

www.sciencedirect.com/science/arti...

#CardioSky

Rab10 plays a protective role in the development of pathological cardiac hypertrophy Prolonged cardiac hypertrophy is a main risk factor for heart failure (HF). During cardiac hypertrophy remodelling, there is an increase in protein sy…

Rab10 to the rescue! 🦸‍♂️🫀!

New study from Xu et al. in the December issue shows how this tiny protein helps keep harmful heart growth in check.

Read more at:
www.sciencedirect.com/science/arti...

#CardioProtection #Hypertrophy #CardioSky

🧵 4/6
Can turmeric & ginger support cardiovascular and gut health? Our review says yes.

🌐 #Cardioprotection #GutHealth #FunctionalFood @nicksevillaz.bsky.social @manjeet786.bsky.social @castltrastondrs.bsky.social @ewingt-phd.bsky.social @diegogarotooficial.bsky.social

Mitochondrial Quality Control and Melatonin: A Strategy Against Myocardial Injury Relationship between melatonin and cardiovascular disease.

#Melatonin protects the heart by improving #MitochondrialQualityControl, reducing oxidative stress and damage during myocardial ischemia-reperfusion injury. It’s a promising strategy for cardiac therapy. #Melatonin #Mitochondria #HeartHealth #Cardioprotection onlinelibrary.wiley.com/doi/10.1002/...

🚨 Last Call for Submissions! 🚨

⏳ Deadline: August 2025 ⏳
📢 Don’t miss your chance to contribute to our Special Issue on Cardioprotection in Drug-Induced Cardiotoxicity.

🔗 Submit now: buff.ly/3uh2lPh

#Cardiotoxicity #Cardioprotection #Pharmacology

Only a few months left to submit to our IJMS Special Issue on
Cardioprotection in Drug-Induced Cardiotoxicity.

Details: www.mdpi.com/journal/ijms...
Deadline: 20/Aug/2025

#Cardiotoxicity #CardioProtection #Pharmacology #CardioOncology #DrugSafety #HeartResearch #CancerTherapy

💡 Cardioprotection & Drug-Induced Cardiotoxicity 💡

Have research on cardioprotective mechanisms, biomarkers, or interventions? 🫀💊 Submit to our Special Issue in IJMS!

📅 Deadline: August 2025
🔗 Details: buff.ly/3uh2lPh

#Cardiotoxicity #Cardioprotection #DrugSafety #Pharmacology #Toxicology

Portfolio diet delays heart risk and lowers cholesterol in young adults A University of Toronto study found that higher adherence to the plant-based Portfolio Diet was associated with lower LDL cholesterol and improved cardiovascular risk markers in young adults. Modeling...

Portfolio diet delays heart risk and lowers cholesterol in young adults www.news-medical.net/news/2025051... #portfoliodiet #plantbaseddiet #hearthealth #youngadults #LDL #cholesterol #nutrition #cardioprotection #publichealth

IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): a small animal acute myocardial infarction randomized-controlled multicenter study on the effect of ischemic preconditioning - Basic Research in Cardiology Although many cardioprotective interventions have been shown to limit infarct size (IS), in preclinical animal studies of acute myocardial ischemia/reperfusion injury (IRI), their clinical…

Excited to have contributed to a groundbreaking study!

This collaborative effort across 8 international sites aimed to enhance the reproducibility of cardioprotective interventions, a crucial step toward effective clinical translation.​
link.springer.com/article/10.1...

#Cardioprotection

Semaglutide proves a game-changer for kidney and heart health in diabetes patients The FLOW trial demonstrated that semaglutide significantly improves kidney and cardiovascular outcomes in people with chronic kidney disease and type 2 diabetes, irrespective of SGLT2 inhibitor use.

Semaglutide proves a game-changer for kidney and heart health in diabetes patients 🔬💊❤️ www.news-medical.net/news/2024062... #Diabetes #KidneyHealth #CardioProtection #Semaglutide #Type2Diabetes #ChronicKidneyDisease @natureportfolio.bsky.social